Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Sandhya Nagubadi, M.D.
Internal Medicine · PALOS HEIGHTS, IL · NPI 1043262207
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 507 | 138 |
| Atorvastatin Calcium | Atorvastatin Calcium | 492 | 139 |
| Eliquis | Apixaban | 318 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 271 | 76 |
| Levothyroxine Sodium | Levothyroxine Sodium | 248 | 55 |
| Gabapentin | Gabapentin | 228 | 59 |
| Losartan Potassium | Losartan Potassium | 215 | 62 |
| Pantoprazole Sodium | Pantoprazole Sodium | 212 | 64 |
| Metformin Hcl | Metformin Hcl | 198 | 57 |
| Lisinopril | Lisinopril | 193 | 56 |
| Furosemide | Furosemide | 171 | 48 |
| Carvedilol | Carvedilol | 139 | 27 |
| Omeprazole | Omeprazole | 134 | 38 |
| Potassium Chloride | Potassium Chloride | 134 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 134 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 132 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 130 | 42 |
| Levetiracetam | Levetiracetam | 127 | 17 |
| Simvastatin | Simvastatin | 118 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 24 |
| Donepezil Hcl | Donepezil Hcl | 97 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 96 | 28 |
| Prednisone | Prednisone | 96 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 93 | 40 |
| Mirtazapine | Mirtazapine | 82 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 78 | 23 |
| Famotidine | Famotidine | 71 | 26 |
| Allopurinol | Allopurinol | 70 | 19 |
| Memantine Hcl | Memantine Hcl | 68 | 17 |
| Montelukast Sodium | Montelukast Sodium | 67 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 65 | 18 |
| Finasteride | Finasteride | 62 | 14 |
| Glipizide | Glipizide | 62 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 62 | 20 |
| Risperidone | Risperidone | 59 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | 13 |
| Januvia | Sitagliptin Phosphate | 51 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 49 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 48 | suppressed |
| Olanzapine | Olanzapine | 47 | suppressed |
| Alprazolam | Alprazolam | 46 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 46 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 44 | 11 |
| Sertraline Hcl | Sertraline Hcl | 44 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 43 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 41 | 16 |
| Trazodone Hcl | Trazodone Hcl | 41 | 13 |
| Ibuprofen | Ibuprofen | 39 | 20 |
| Spironolactone | Spironolactone | 39 | 14 |
| Metformin Hcl Er | Metformin Hcl | 38 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 37 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 36 | 12 |
| Meloxicam | Meloxicam | 34 | 14 |
| Lovastatin | Lovastatin | 33 | suppressed |
| Methimazole | Methimazole | 33 | suppressed |
| Haloperidol | Haloperidol | 32 | suppressed |
| Nystatin | Nystatin | 32 | 14 |
| Ozempic | Semaglutide | 32 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 31 | 14 |
| Bupropion Hcl | Bupropion Hcl | 30 | suppressed |
| Ezetimibe | Ezetimibe | 30 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 20 |
| Nifedipine Er | Nifedipine | 29 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Fluconazole | Fluconazole | 27 | 15 |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Latanoprost | Latanoprost | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Clozapine | Clozapine | 23 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 23 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 22 | suppressed |
| Azithromycin | Azithromycin | 22 | 18 |
| Cephalexin | Cephalexin | 22 | 18 |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Mounjaro | Tirzepatide | 22 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Tradjenta | Linagliptin | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Jardiance | Empagliflozin | 20 | 11 |
| Sodium Chloride | 0.9 % Sodium Chloride | 20 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 19 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Letrozole | Letrozole | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 14 |
| Baclofen | Baclofen | 17 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Clonidine | Clonidine | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 16 |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 15 |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 15 | 13 |
| Bumetanide | Bumetanide | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Indapamide | Indapamide | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Trandolapril | Trandolapril | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Risperidone Odt | Risperidone | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error